miR-651-3p Enhances the Sensitivity of Hepatocellular Carcinoma to Cisplatin via Targeting ATG3-Mediated Cell Autophagy

Drug resistance is a major challenge for hepatocellular carcinoma (HCC) treatment in a clinic, which limits the therapeutic effect of the chemotherapeutic drugs, including cisplatin (CDDP), in this disease. Mounting evidence has identified that miRNAs dysfunction is related to the resistance of tumo...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Lei, Sun, Peng, Zhang, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390158/
https://www.ncbi.nlm.nih.gov/pubmed/34457004
http://dx.doi.org/10.1155/2021/5391977

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390158/
https://www.ncbi.nlm.nih.gov/pubmed/34457004
http://dx.doi.org/10.1155/2021/5391977

Ejemplares similares